102 related articles for article (PubMed ID: 21292492)
1. Modulation of the activity of histone acetyltransferases by long chain alkylidenemalonates (LoCAMs).
Milite C; Castellano S; Benedetti R; Tosco A; Ciliberti C; Vicidomini C; Boully L; Franci G; Altucci L; Mai A; Sbardella G
Bioorg Med Chem; 2011 Jun; 19(12):3690-701. PubMed ID: 21292492
[TBL] [Abstract][Full Text] [Related]
2. Identification of long chain alkylidenemalonates as novel small molecule modulators of histone acetyltransferases.
Sbardella G; Castellano S; Vicidomini C; Rotili D; Nebbioso A; Miceli M; Altucci L; Mai A
Bioorg Med Chem Lett; 2008 May; 18(9):2788-92. PubMed ID: 18434144
[TBL] [Abstract][Full Text] [Related]
3. Improved inhibition of the histone acetyltransferase PCAF by an anacardic acid derivative.
Ghizzoni M; Boltjes A; Graaf Cd; Haisma HJ; Dekker FJ
Bioorg Med Chem; 2010 Aug; 18(16):5826-34. PubMed ID: 20655754
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of benzamides related to anacardic acid and their histone acetyltransferase (HAT) inhibitory activities.
Souto JA; Conte M; Alvarez R; Nebbioso A; Carafa V; Altucci L; de Lera AR
ChemMedChem; 2008 Sep; 3(9):1435-42. PubMed ID: 18537201
[TBL] [Abstract][Full Text] [Related]
5. Deciphering the binding mode and mechanistic insights of pentadecylidenemalonate (1b) as activator of histone acetyltransferase PCAF.
Suryanarayanan V; Singh SK
J Biomol Struct Dyn; 2019 Jun; 37(9):2296-2309. PubMed ID: 30044210
[TBL] [Abstract][Full Text] [Related]
6. New anacardic acid-inspired benzamides: histone lysine acetyltransferase activators.
Souto JA; Benedetti R; Otto K; Miceli M; Alvarez R; Altucci L; de Lera AR
ChemMedChem; 2010 Sep; 5(9):1530-40. PubMed ID: 20683922
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and biological testing of novel pyridoisothiazolones as histone acetyltransferase inhibitors.
Furdas SD; Shekfeh S; Bissinger EM; Wagner JM; Schlimme S; Valkov V; Hendzel M; Jung M; Sippl W
Bioorg Med Chem; 2011 Jun; 19(12):3678-89. PubMed ID: 21353783
[TBL] [Abstract][Full Text] [Related]
8. The histone acetylase activator pentadecylidenemalonate 1b rescues proliferation and differentiation in the human cardiac mesenchymal cells of type 2 diabetic patients.
Vecellio M; Spallotta F; Nanni S; Colussi C; Cencioni C; Derlet A; Bassetti B; Tilenni M; Carena MC; Farsetti A; Sbardella G; Castellano S; Mai A; Martelli F; Pompilio G; Capogrossi MC; Rossini A; Dimmeler S; Zeiher A; Gaetano C
Diabetes; 2014 Jun; 63(6):2132-47. PubMed ID: 24458358
[TBL] [Abstract][Full Text] [Related]
9. Identification of structural features of 2-alkylidene-1,3-dicarbonyl derivatives that induce inhibition and/or activation of histone acetyltransferases KAT3B/p300 and KAT2B/PCAF.
Castellano S; Milite C; Feoli A; Viviano M; Mai A; Novellino E; Tosco A; Sbardella G
ChemMedChem; 2015 Jan; 10(1):144-57. PubMed ID: 25333655
[TBL] [Abstract][Full Text] [Related]
10. Histone acetylation modulation by small molecules: a chemical approach.
Rekowski Mv; Giannis A
Biochim Biophys Acta; 2010; 1799(10-12):760-7. PubMed ID: 20493978
[TBL] [Abstract][Full Text] [Related]
11. 6-alkylsalicylates are selective Tip60 inhibitors and target the acetyl-CoA binding site.
Ghizzoni M; Wu J; Gao T; Haisma HJ; Dekker FJ; George Zheng Y
Eur J Med Chem; 2012 Jan; 47(1):337-44. PubMed ID: 22100137
[TBL] [Abstract][Full Text] [Related]
12. HATs and HDACs: from structure, function and regulation to novel strategies for therapy and prevention.
Yang XJ; Seto E
Oncogene; 2007 Aug; 26(37):5310-8. PubMed ID: 17694074
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of isothiazol-3-one derivatives as inhibitors of histone acetyltransferases (HATs).
Gorsuch S; Bavetsias V; Rowlands MG; Aherne GW; Workman P; Jarman M; McDonald E
Bioorg Med Chem; 2009 Jan; 17(2):467-74. PubMed ID: 19101154
[TBL] [Abstract][Full Text] [Related]
14. New potent bisubstrate inhibitors of histone acetyltransferase p300: design, synthesis and biological evaluation.
Kwie FH; Briet M; Soupaya D; Hoffmann P; Maturano M; Rodriguez F; Blonski C; Lherbet C; Baudoin-Dehoux C
Chem Biol Drug Des; 2011 Jan; 77(1):86-92. PubMed ID: 21118378
[TBL] [Abstract][Full Text] [Related]
15. Bisubstrate analogue structure-activity relationships for p300 histone acetyltransferase inhibitors.
Sagar V; Zheng W; Thompson PR; Cole PA
Bioorg Med Chem; 2004 Jun; 12(12):3383-90. PubMed ID: 15158807
[TBL] [Abstract][Full Text] [Related]
16. Identification of 4-hydroxyquinolines inhibitors of p300/CBP histone acetyltransferases.
Mai A; Rotili D; Tarantino D; Nebbioso A; Castellano S; Sbardella G; Tini M; Altucci L
Bioorg Med Chem Lett; 2009 Feb; 19(4):1132-5. PubMed ID: 19144517
[TBL] [Abstract][Full Text] [Related]
17. Histone acetyl transferases as emerging drug targets.
Dekker FJ; Haisma HJ
Drug Discov Today; 2009 Oct; 14(19-20):942-8. PubMed ID: 19577000
[TBL] [Abstract][Full Text] [Related]
18. A novel histone acetyltransferase inhibitor modulating Gcn5 network: cyclopentylidene-[4-(4'-chlorophenyl)thiazol-2-yl)hydrazone.
Chimenti F; Bizzarri B; Maccioni E; Secci D; Bolasco A; Chimenti P; Fioravanti R; Granese A; Carradori S; Tosi F; Ballario P; Vernarecci S; Filetici P
J Med Chem; 2009 Jan; 52(2):530-6. PubMed ID: 19099397
[TBL] [Abstract][Full Text] [Related]
19. Enzyme kinetics and inhibition of histone acetyltransferase KAT8.
Wapenaar H; van der Wouden PE; Groves MR; Rotili D; Mai A; Dekker FJ
Eur J Med Chem; 2015 Nov; 105():289-96. PubMed ID: 26505788
[TBL] [Abstract][Full Text] [Related]
20. Bisubstrate Inhibitors of the MYST HATs Esa1 and Tip60.
Wu J; Xie N; Wu Z; Zhang Y; Zheng YG
Bioorg Med Chem; 2009 Feb; 17(3):1381-6. PubMed ID: 19114310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
